MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Tauopathies"

  • MDS Virtual Congress 2020

    18kDa Translocator Protein PET in 4-Repeat Tauopathies – A Cross-Sectional Single Center Study

    C. Palleis, J. Sauerbeck, L. Beyer, S. Harris, J. Schmitt, A. Finze, A. Nitschmann, G. Biechele, K. Boetzel, A. Danek, B. Rauchmann, M. Unterrainer, N. Albert, R. Rupprecht, P. Bartenstein, R. Perneczky, C. Haass, J. Levin, G. Hoeglinger, M. Brendel (Munich, Germany)

    Objective: The aim of this single center study was to analyse the potential of 18F-GE-180 TSPO PET as a biomarker in 4R-tauopathies. Background: The pathological…
  • MDS Virtual Congress 2020

    Long and short survival in Parkinson syndrome: pathology and genetics are key prognostic factors

    A. Rajput, C. Robinson, M. Farrer, E. Gustavsson, A. Rajput (Saskatoon, SK, Canada)

    Objective: To study the clinical, pathological and genetic profile of Parkinson syndrome (PS) cases that have > 20 years survival (long survival, or LS) compared…
  • MDS Virtual Congress 2020

    No frank biochemical evidence of proteinopathy in the cerebellar cortex of patients with essential tremor

    A. Rajput, A. Rajput, C. Tremblay, F. Calon, K. Melançon, E. Aubry-Lafontaine, E. Brochu, S. Paris-Robidas (Quebec, QC, Canada)

    Objective: This study was designed to determine the presence of common types of proteinopathies in the cerebellar cortex of patients who died with essential tremor…
  • 2019 International Congress

    Complement C3a receptor antagonist attenuates tau hyperphosphorylation via glycogen synthase kinase 3β signaling pathways

    JJ. Hu, T. Wang (Wuhan, China)

    Objective: To investigate the role and mechanism of C3a receptor in okadaic acid(OA) induced SH-SY5Y cells tau hyperphosphorylation model Background: Neurofibrillary tangles aggregated from hyperphosphorylated…
  • 2019 International Congress

    Heavy metals implicated in a geographical cluster of progressive supranuclear palsy induce tau accumulation and apoptotic cell death in cultured neurons

    C. Alquezar, J. Felix, E. Mccandlish, B. Buckley, D. Caparros-Lefebvre, C. Karch, L. Golbe, A. Kao (San Francisco, CA, USA)

    Objective: To test the hypothesis that certain metals may cause cellular damage suggesting tauopathy. This is an early step in testing the hypothesis that environmental…
  • 2019 International Congress

    Cortical and subcortical atrophy in typical and variant Parkinson-plus syndromes: PROSPECT-M-UK study

    N. Holland, S. Jones, J. Woodside, E. Jabbari, V. Chelban, A. Costantini, PN. Leigh, D. Burn, N. Pavese, A. Gerhard, C. Kobylecki, M. Hu, A. Church, J. Rohrer, H. Houlden, H. Morris, J. Rowe (Cambridge, United Kingdom)

    Objective: To investigate grey matter volume in typical and variant Parkinson-plus syndromes, to correlate these with disease severity, and to assess regional atrophy within disease…
  • 2019 International Congress

    Clinico-pathological Findings In Autopsy Cases With Non-Specific Glial Tauopathy

    E. Zamrini, CH. Adler, GE. Serrano, N. Zhang, DR. Shprecher, SH. Mehta, MN. Sabbagh, E. Driver-Dunckley, HA. Shill, LI. Sue, TG. Beach (Sun City, AZ, USA)

    Objective: Determine Clinico-pathological correlates of aging-related tau astrogliopathy (ARTAG). Background: Aging-related tau astrogliopathy (ARTAG) appears to be a morphological spectrum of astroglial pathology mostly seen in…
  • 2019 International Congress

    Differential Gene Expression in Parkinson Disease and Chronic Traumatic Encephalopathy

    FV. Delos Reyes (Quezon City, Philippines)

    Objective: The research would like to determine if similar overexpressed genes between CTE and PD may explain the occurrence of parkinsonism in CTE. This was…
  • 2019 International Congress

    A novel intronic variant in MAPT causes FTLD-parkinsonism: Implications for regulatory mechanism of MAPT pre-mRNA splicing

    P. Gonzalez-Latapi, B. Bustos, D. Larson, L. Kinsley, N. Siddique, T. Siddique, T. Simuni, E. Bigio, S. Lubbe, R. de Silva, D. Krainc, N. Mencacci (Chicago, IL, USA)

    Objective: To report the identification of a novel intronic variant in MAPT in a patient with familial parkinsonism-frontotemporal lobar degeneration (FTLD). Background: MAPT mutations are…
  • 2019 International Congress

    Activity of Cerebral Networks, Amyloid and Microglia in Corticobasal Syndrome: the ActiGliA study

    C. Palleis, J. Levin, M. Brendel, L. Beyer, BS. Rauchmann, S. Loosli, E. Wlasich, K. Boetzel, A. Danek, R. Perneczky, C. Haass, G. Hoeglinger (Munich, Germany)

    Objective: The purpose of this prospective cohort study is to analyse the topographical and temporal relationship between cerebral microglia activity changes, network degeneration and atrophy…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 14
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley